Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-13 · accession 0001579397-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-15 | 2026-01-13+ | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | S - Sale | $28.70 | -103.8K | 139.7K | -43% | -$2.98M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | S | D | 3,822 | $28.01 | 239,727 | D | — | — | (F1) The weighted average sale price for the transaction reported was $28.01, and the range of prices were between $28.00 and $28.03. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2026-01-15 | S | D | 100,000 | $28.73 | 139,727 | D | — | — | (F2) The weighted average purchase price for the transaction reported was $28.73, and the range of prices were between $28.50 and $29.18. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided. |